Prenatal exposure to curcumin protects rod photoreceptors in a transgenic Pro23his swine model of retinitis pigmentosa

Translational Vision Science and Technology

Volumn 4, Issue 5, 2015, Pages

  Scott, Patrick A ^a   Kaplan, Henry J ^a   McCall, Maureen A ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; RHODOPSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL INSEMINATION; BIRTH; FEEDING; GENOTYPE; IMMUNOHISTOCHEMISTRY; MICROPHOTOGRAPHY; MORPHOLOGY; NEUROPROTECTION; NONHUMAN; PRENATAL EXPOSURE; RETINA ROD; RETINAL THICKNESS; RETINITIS PIGMENTOSA; SOW (SWINE); TRANSGENIC PIG; TRANSMISSION ELECTRON MICROSCOPY;

EID: 85016221132     PISSN: None     EISSN: 21642591     Source Type: Journal    
DOI: 10.1167/tvst.4.5.5     Document Type: Article

References (41)

1. Berson E. Retinitis pigmentosa: the Friedenwald lecture. Invest Ophthalmol Vis Sci. 1993;34:1659–1676.
2. Milam AH, Li Z-Y, Fariss RN. Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res. 1998;17:175–205.
3. Berson EL, Gouras P, Gunkel RD. Rod response in retinitis pigmentosa, dominantly inherited. Arch Ophthalmol. 1968;80:58–67.
4. Berson EL, Simonoff EA. Dominant retinitis pigmentosa with reduced penetrance. Further studies with the electroretinogram. Arch Ophthalmol. 1979;97:1286–1291.
5. Berson EL, Gouras P, Gunkel RD, Myrianthopoulos NC. Rod response in sex-linked retinitis pigmentosa. Arch Ophthalmol. 1968;81:215–225.
6. Cideciyan AV, Jacobson SG, Beltran WA, et al. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proc Natl Acad Sci. 2013;110:E517–E525.
7. Simonelli F, Maguire AM, Testa F, et al. Gene therapy for Leber’s congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther. 2010;18:643–650.
8. Rivas MA, Vecino E. Animal models and different therapies for treatment of retinitis pigmentosa. Histol Histopathol. 2009;24:1295–1322.
9. Chader GJ, Weiland J, Humayun MS. Artificial vision: needs, functioning, and testing of retinal electronic prosthesis. Prog Brain Res. 2009;175: 317–332.
10. Rizzo S, Belting C, Cinelli L, et al. The Argus II retinal prosthesis: 12-month outcomes from a single-study center. Am J Ophthalmol. 2014;157: 1282–1290.
11. Wiley LA, Burnight ER, Songstad AE, et al. Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases. Prog Retin Eye Res. 2015; 44C:15–35.
12. Burnight ER, Wiley LA, Mullins RF, Stone EM, Tucker BA. Gene therapy using stem cells [published online ahead of print November 13, 2014]. Cold Spring Harb Perspect Med. doi: 10.1101/cshperspect.a017434.
13. He Y, Zhang Y, Su G. Recent advances in treatment of retinitis pigmentosa. Curr Stem Cell Res Ther. 2015;10:258–265.
14. He Y, Zhang Y, Liu X, Ghazaryan E, Li Y, Xie J, Su G. Recent advances of stem cell therapy for retinitis pigmentosa. Int J Mol Sci. 2014;15: 14456–14474.
15. Petrs-Silva H, Linden R. Advances in gene therapy technologies to treat retinitis pigmentosa. Clin Ophthalmol. 2014;8:127–136.
16. Garg SJ, Federman J. Optogenetics, visual prosthesis and electrostimulation for retinal dystrophies. Curr Opin Ophthalmol. 2013;24; 407–414.
17. Vasireddy V, Chavali VRM, Joseph VT, et al. Rescue of photoreceptor degeneration by curcumin in transgenic rats with P23H rhodopsin mutation. PLoS One. 2011;6:e21193.
18. Dryja TP, McGee TL, Reichel E, et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature. 1990;343:364–366.
19. Alfinito PD, Townes-Anderson E. Activation of mislocalized opsin kills rod cells: a novel mechanism for rod cell death in retinal disease. Proc Natl Acad Sci USA. 2002;99:5655–5660.
20. Sung CH, Makino C, Baylor D, Nathans J. A rhodopsin gene mutation responsible for autosomal dominant retinitis pigmentosa results in protein that is defective in localization to the photoreceptor outer segment. J Neurosci. 1994; 14:5818–5833.
21. Agarwal N, Nir I, Papermaster DS. Expression of opsin and IRBP genes in mutant RCS rats. Exp Eye Res. 1992;54:545–554.
22. Roof DJ, Adamian M, Hayes A. Rhodopsin accumulation at abnormal sites in retinas of mice with a human P23H rhodopsin transgene. Invest Ophthalmol Vis Sci. 1994;35:4049–4062.
23. Price BA, Sandoval IM, Chan F, Simons DL, et al. Mislocalization and degradation of human P23H-rhodopsin-GFP in a knockin mouse model of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2011;52:9728–9736.
24. Nir I, Papermaster DS. Immunocytochemial localization of opsin in degenerating photoreceptors of RCS rats and rd and rds mice. Prog Clin Biol Res. 1989;314:251–264.
25. Li YZ, Wong F. Chang, et al. Rhodopsin transgenic pigs as a model for human retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1998;39: 808–819.
26. Tam BM, Moritz OL. Characterization of rhodopsin P23H-induced retinal degeneration in a Xenopus laevis model of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2006;47:3234–3241.
27. Wang J, Zhang N, Beuve A, Townes-Anderson E. Mislocalized opsin and cAMP signaling: a mechanism for sprouting by rod cells in retinal degeneration. Invest Ophthalmol Vis Sci. 2012;53: 6355–6369.
28. Scott PA, Fernandez de Castro, JP, Kaplan HJ, McCall MAA. Pro23His mutation alters prenatal rod photoreceptor morphology in a transgenic swine model of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2014;55:2452–2459.
29. Ross JW, Fernandez de Castro JP, Zhao J, et al. Generation of an inbred miniature pig model of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2012;53:501–507.
30. Fernandez de Castro JP, Scott PA, Fransen JW, et al. Cone photoreceptors develop normally in the absence of rod photoreceptors in a transgenic swine model of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2014;55:2460–2468.
31. Léveillard T, Mohand-Said Lorentz, S, Hicks D, et al. Identification and characterization of rodderived cone viability factor. Nat Genet. 2004;36: 755–759.
32. Léveillard T, Sahel JA. Rod-derived cone viability factor for treating blinding diseases: from clinic to redox signaling. Sci Transl Med. 2010;26: 26ps16.
33. Yang Y, Mohand-Said S, Danan A, et al. Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa. Mol Ther. 2009;17:787–795.
34. Elachouri G, Lee-Rivera I, Clérin E, et al. Thioredoxin rod-derived cone viability factor protects against photooxidative retinal damage. Free Radic Biol Med. 2015;81C:22–29.
35. Byrne LC, Dalkara D, Luna G, et al. Viralmediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration. J Clin Invest. 2015;125:105–116.
36. Fernández-Sánchez L, Lax P, Esquiva G, Martin-Nieto J, Pinilla I, Cuenca N. Safranal, a saffron constituent, attenuates retinal degeneration in P23H rats. PLoS One. 2012;7:e43074.
37. Lax P, Esquiva G, Altavilla C, Cuenca N. Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration. Exp Eye Res. 2014;120:175–185.
38. Fernández-Sánchez L, Lax P, Pinilla I, Martin-Nieto J, Cuenca N. Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats. Invest Ophthalmol Vis Sci. 2011;52:4998–5008.
39. Fernández-Sánchez L, Lax P, Isiegas C, et al. Proinsulin slows retinal degeneration and vision loss in the P23H rat model of retinitis pigmentosa. Hum Gene Ther. 2012;23:1290–1300.
40. Ozaki T, Ishiguro S, Hirano S, et al. Inhibitory peptide of mitochondrial m-calpain protects against photoreceptor degeneration in rhodopsin transgenic S334ter and P23H rats. PLoS One. 2013;8:e71650.
41. Parfitt DA, Aguila M, McCulley CH, et al. The heat-shock response co-inducer arimoclomol protects against retinal degeneration in rhodopsin retinitis pigmentosa. Cell Death Dis. 2014;5: e1236.